Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CD40に対する抗体
Document Type and Number:
Japanese Patent JP5848232
Kind Code:
B2
Abstract:
The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to CD40, preferably human CD40, and that function as CD40 agonists. The invention also relates to human anti-CD40 antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-CD40 antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-CD40 antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-CD40 antibodies. The invention also relates to transgenic animals comprising nucleic acid molecules of the present invention.

Inventors:
Bedian Buffet
Graduone Ronald Pee.
Corbalan Jose
Ja Xiao
Feng Xiao
Application Number:
JP2012270885A
Publication Date:
January 27, 2016
Filing Date:
December 12, 2012
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Pfizer Products Inc.
Amgen Fremont Ink.
International Classes:
A01H5/00; C12N15/09; A01H1/00; A01K67/027; A61K31/7088; A61K35/76; A61K39/395; A61K48/00; A61P13/08; A61P13/10; A61P35/00; A61P35/02; A61P43/00; C07K16/28; C07K16/40; C07K16/46; C12N1/15; C12N1/19; C12N1/21; C12N5/06; C12N5/10; C12N15/02; C12N15/12; C12P21/02; C12P21/08; C07K
Foreign References:
WO2001083755A1
WO1995017202A1
Attorney, Agent or Firm:
Shimizu Hatsushi
Toshi Gobe
Koichi Niimi
Kazuya Kawamoto



 
Previous Patent: 車両遠隔操作システム

Next Patent: JPS5848233